Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

PharmaEssentia Corp. (6446) Stock Price & Analysis

6446 Stock Chart & Stats

NT$1,270.00NT$85.00(7.17%)
At close: 12:30 AM EST
TWD 1.2KTWD 1.4KTWD 1.6KAug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
TWD 1,075.00 - TWD 1,295.00
52-Week Range
TWD 407.92 - TWD 1,645.00
Previous Close
TWD 1,185.00
Volume
N/A
Average Volume (3M)
1.93M
Market Cap
TWD 523.94B
Enterprise Value
TWD 475.32B
Total Cash (Recent Filing)
TWD 24.47B
Total Debt (Recent Filing)
TWD 1.02B
Price to Earnings (P/E)
68.6
Beta
0.64
Next Earnings
Nov 11, 2026 (Est.)
EPS Estimate
6.65
Last Dividend Ex-Date
Jul 09, 2026
Dividend Yield
0.12%

Bulls Say, Bears Say

Bulls Say

Revenue And Profitability Rebound

The sharp revenue acceleration and return to strong net profitability indicate meaningful improvement in commercial execution and operating scale. If maintained, this earnings base can support continued investment in the biologics portfolio, strengthen internal funding capacity, and improve long-term resilience.

Exceptional Gross Margins

Sustained gross margins near 87–88% provide substantial economic value per unit of revenue and create room to absorb development, commercialization, and operating costs. This profitability profile can support reinvestment in specialty medicines while preserving attractive earnings potential over the next several quarters.

Conservative Balance Sheet

Very low leverage gives PharmaEssentia considerable financial flexibility and reduces the burden of interest or refinancing obligations. A growing asset and equity base also provides stronger support for research, commercialization, and other strategic investments if operating conditions become less favorable.

Bears Say

Historical Earnings Volatility

The recent turnaround is encouraging, but the preceding period of heavy losses shows that profitability has not yet been demonstrated across a full operating cycle. A return of weaker results would reduce internally generated funding and make the current earnings profile less dependable for long-term planning.

Cyclical Cash Generation

Cash flow that has been negative for several prior years indicates that accounting profitability may not consistently translate into available cash under different conditions. Although the latest recovery is strong, continued variability could constrain investment, reduce financial flexibility, and complicate capital allocation decisions.

Incomplete Cash Conversion

Conversion of net income into free cash flow at roughly 64% means a meaningful portion of reported earnings remains tied to reinvestment or working capital. While this may support growth, persistently lower conversion would limit distributable cash and make earnings quality more dependent on operational execution.

PharmaEssentia Corp. News

6446 FAQ

What was PharmaEssentia Corp.’s price range in the past 12 months?
PharmaEssentia Corp. lowest stock price was TWD 407.92 and its highest was TWD 1645.00 in the past 12 months.
What is PharmaEssentia Corp.’s market cap?
PharmaEssentia Corp.’s market cap is TWD 523.94B.
When is PharmaEssentia Corp.’s upcoming earnings report date?
PharmaEssentia Corp.’s next earnings report is estimated for Nov 11, 2026 (not yet confirmed), which is today.
How were PharmaEssentia Corp.’s earnings last quarter?
PharmaEssentia Corp. released its earnings results on Aug 10, 2026. The company reported TWD 6.13 earnings per share for the quarter, missing the consensus estimate of TWD 6.219 by -TWD 0.089.
Is PharmaEssentia Corp. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PharmaEssentia Corp. pay dividends?
PharmaEssentia Corp. pays a ― dividend of TWD 1.5 which represents an annual dividend yield of 0.12%. See more information on PharmaEssentia Corp. dividends here
What is PharmaEssentia Corp.’s EPS estimate?
PharmaEssentia Corp.’s EPS estimate is 6.65.
How many shares outstanding does PharmaEssentia Corp. have?
PharmaEssentia Corp. has 422,434,630 shares outstanding.
What happened to PharmaEssentia Corp.’s price movement after its last earnings report?
PharmaEssentia Corp. reported an EPS of TWD 6.13 in its last earnings report, missing expectations of TWD 6.219. Following the earnings report the stock price went up 9.774%.
Which hedge fund is a major shareholder of PharmaEssentia Corp.?
Currently, no hedge funds are holding shares in TW:6446
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology